DekaBank Deutsche Girozentrale - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$540
-16.1%
32,292
+14.9%
0.00%0.0%
Q2 2023$644
+2.4%
28,1000.0%0.00%
-50.0%
Q1 2023$629
+54.2%
28,1000.0%0.00%
+100.0%
Q4 2022$408
-99.9%
28,1000.0%0.00%
-50.0%
Q3 2022$544,000
+6.0%
28,1000.0%0.00%
+100.0%
Q2 2022$513,000
-28.5%
28,1000.0%0.00%
-50.0%
Q1 2022$717,000
+2.3%
28,100
+10.2%
0.00%0.0%
Q4 2021$701,000
-12.5%
25,500
+2.8%
0.00%0.0%
Q3 2021$801,000
+6.8%
24,8000.0%0.00%0.0%
Q2 2021$750,000
+4.0%
24,8000.0%0.00%0.0%
Q1 2021$721,000
+60.6%
24,8000.0%0.00%0.0%
Q4 2020$449,000
+38.6%
24,800
-4.6%
0.00%
+100.0%
Q3 2020$324,000
-57.5%
26,000
-3.0%
0.00%
-80.0%
Q3 2019$763,000
-24.2%
26,800
-28.7%
0.01%0.0%
Q2 2019$1,006,000
-11.4%
37,600
+64.2%
0.01%
-28.6%
Q1 2019$1,135,000
+112.1%
22,900
+21.8%
0.01%
+75.0%
Q4 2018$535,000
-52.9%
18,800
-17.9%
0.00%
-42.9%
Q3 2018$1,135,000
+30.0%
22,900
-2.6%
0.01%
+16.7%
Q2 2018$873,000
-24.6%
23,500
-40.0%
0.01%
-25.0%
Q1 2018$1,158,000
-9.2%
39,151
-14.5%
0.01%
-20.0%
Q4 2017$1,275,0000.0%45,7930.0%0.01%0.0%
Q3 2017$1,275,000
+8.3%
45,7930.0%0.01%
+11.1%
Q2 2017$1,177,000
+156.4%
45,793
+90.8%
0.01%
+125.0%
Q1 2017$459,000
+5.8%
24,000
-7.7%
0.00%
-20.0%
Q4 2016$434,000
-12.7%
26,000
+8.3%
0.01%
-16.7%
Q3 2016$497,000
-23.8%
24,000
+12.5%
0.01%
-14.3%
Q2 2016$652,000
-82.1%
21,326
-78.1%
0.01%
-83.7%
Q1 2016$3,633,000
+20.8%
97,500
+42.3%
0.04%
+26.5%
Q4 2015$3,007,000
+129.9%
68,500
+96.3%
0.03%
+112.5%
Q3 2015$1,308,000
+11.2%
34,900
+0.9%
0.02%
+14.3%
Q2 2015$1,176,000
-0.3%
34,600
+3.9%
0.01%
-6.7%
Q1 2015$1,179,000
-13.2%
33,300
-14.6%
0.02%
-11.8%
Q4 2014$1,358,000
-17.3%
39,000
-8.5%
0.02%
-22.7%
Q3 2014$1,643,000
-1.6%
42,600
-0.7%
0.02%
-12.0%
Q2 2014$1,670,000
-3.3%
42,900
-15.0%
0.02%
-7.4%
Q1 2014$1,727,000
+81.4%
50,500
+10.3%
0.03%
+68.8%
Q4 2013$952,000
-9.0%
45,800
+2.9%
0.02%
-11.1%
Q3 2013$1,046,00044,5000.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders